The Story: A Founder Who Said No, Twelve Times
Jack Jia built Musely the hard way. Founded in 2014 as a wellness community, the company pivoted in 2019 to become a direct-to-consumer telemedicine platform specializing in compounded skincare, hair, and menopause treatments. Over the next six years, Musely grew revenue at roughly 50% year-over-year, reached more than 1.2 million patients, and did something almost unheard of in the DTC world: it stayed cash flow positive the entire time.
So when venture capitalists came knocking (and they came often) Jia said no. Every single time. Since a $20 million seed round from DCM in 2014, Musely had not taken a single dollar of outside equity. Jia wasn’t philosophically opposed to capital. He was opposed to what that capital cost at the terms VCs were offering. Dilution, board control, exit pressure, misaligned timelines, none of it fit the business he was building.
That changed in early 2025 when General Catalyst’s Customer Value Fund (CVF) reached out. Not to buy equity. Not to offer a loan. Instead, CVF proposed something structurally different: a revenue-share agreement sized at over $360 million: in exchange for a small, fixed, capped percentage of the revenue Musely would generate from deploying that capital. No interest rate in the traditional sense. No board seat. No dilution. Jia’s ownership position: untouched.
Jia was skeptical at first. But when he built the financial model, his reaction was blunt: “I found this absolutely compelling.”
Source: techcrunch.com
The Decision: Model the Math, Not the Marketing
To understand why Jia’s decision matters, you have to understand the economics of DTC growth at scale. Customer acquisition in prescription skincare is expensive. Jia described the dynamic with unusual clarity: “When you become a billion-dollar revenue company, you need another billion in order to grow to the next billion.” It is a capital-intensive treadmill that has destroyed the balance sheets of countless DTC brands, from Casper to Peloton, precisely because they funded that acquisition cost with equity at high valuations and burned investor capital chasing growth they couldn’t sustain.
Jia’s three real options were:
- Traditional VC Equity Round: High headline valuation, but significant dilution. Board seats, liquidation preferences, and an implicit clock ticking toward a VC-driven exit. Given Musely’s growth profile, a round would likely have valued the company well, but the cost of that capital in ownership terms would have been steep.
- Conventional Bank Debt: Lower cost in percentage terms but rigid in structure. Traditional bank loans come with covenants, amortization schedules, and collateral requirements that don’t flex with DTC revenue cycles. As Jia noted, CVF’s structure was more favorable than a standard bank loan.
- CVF Revenue-Share Agreement: A fixed, capped revenue participation, not open-ended like a royalty stream, and not compounding like a loan. The capital was purpose-deployed for customer acquisition, and the repayment was structurally tied to the revenue that capital generated. Misalignment risk was low. Dilution risk: zero.
The CVF structure also carried a critical feature: it was sized to match Musely’s actual growth ambition. At $360 million, this wasn’t a bridge to the next equity round. It was a war chest. The capital would fund sales, marketing, and customer acquisition, the exact engine of a DTC business that compounds when fed correctly.
Source: techcrunch.com
The Outcome: Equity Preserved, Runway Expanded
Musely’s story doesn’t sit in isolation. Across industries and company sizes, founders who chose structured non-dilutive financing over equity rounds in the same period have reported strikingly similar outcomes: preserved ownership, accelerated growth, and cleaner cap tables at exit or the next funding milestone.
At Vyopta, a collaboration analytics software company based in Austin, TX, the decision to partner with growth debt provider Vistara Growth in May 2020, rather than take a dilutive venture round, meant the founding team went four years without dilution before being acquired by HP in June 2024. Vistara provided a non-amortizing term loan without requiring fresh equity from existing investors, a condition most venture lenders at the time were demanding. The result: a clean cap table, a profitable growth profile, and a strategic buyer in HP who valued exactly those characteristics. Source: vistaragrowth.com
At UnityLab (formerly Unity Laundry Systems), CEO Jonathan used revenue-based financing from Sage Growth Capital to grow a $700,000 startup more than tenfold in four years (including funding a strategic acquisition of Hoffman, an industrial equipment business) without reaching for a traditional equity round until the timing was genuinely optimal. When the Series A did arrive, in Q3 2022, it totaled $6.6 million at a valuation that reflected the business’s proven execution rather than speculative promise. Source: sagegrowthcapital.com
At Inkle, the fintech platform for VC-backed startups, non-dilutive financing from Efficient Capital Labs allowed the founding team to retain approximately 90% of company equity while avoiding two separate dilutive rounds (a seed and a pre-Series A) that would have been their only alternative. The engineering team expanded 50% faster than it otherwise could have. Board control remained with the founders throughout. Source: ecaplabs.com
And at Modigi, a SaaS company serving enterprise clients in the Salesforce ecosystem, CEO Ken Hoppe used $400,000 in revenue financing from Founderpath to hire his first sales and customer success team members, hitting $1.7 million ARR profitably with six employees and retaining 100% founder ownership. Source: founderpath.com
The Lessons: When Non-Dilutive Financing Wins, and When It Doesn’t
The pattern across Musely, Vyopta, UnityLab, Inkle, and Modigi isn’t coincidence. It reflects a fundamental principle: the cost of equity is almost always underestimated by founders at the time of raising, and almost always overstated in hindsight. When a business has predictable, recurring, or compounding revenue (and the capital need is tied to a specific, modelable use case) non-dilutive financing structures can deliver superior outcomes for founders on every economic metric that matters at exit.
But the model has clear prerequisites. Revenue-based and growth debt structures are not for every business. They work when:
- Revenue is predictable and recurring. Underwriters of non-dilutive capital need visibility into repayment. SaaS ARR, DTC subscription models, and service contracts with enterprise clients all fit. Pre-revenue or highly lumpy revenue does not.
- The use of capital is specific and ROI-modelable. Musely deployed $360M into customer acquisition with clear lifetime value data. Modigi funded two specific roles. The tighter the deployment thesis, the more defensible the financing structure.
- The founder genuinely values control. Non-dilutive structures work best when the owner has a long-term view, either building to a specific strategic exit or operating as a permanent capital vehicle. Founders who want to maximize the next round’s headline valuation may find equity more useful as a signaling tool.
- Equity alternatives are expensive relative to fundamentals. If your business is growing 50% year-over-year and cash flow positive, VC terms will almost certainly undervalue you relative to where the business will be in 18 months. That gap is the real cost of equity, and non-dilutive financing lets you capture it yourself.
The emerging ecosystem of CVF-style instruments, growth debt, and revenue-based financing providers has meaningfully expanded founder optionality in 2025 and 2026. For capital-efficient operators with strong unit economics, the era of “raise VC or bootstrap” as the only binary has quietly ended.
Key Insights
- 🔑 Revenue-share structures can be cheaper than both bank debt and equity when modeled against long-term ownership value, Musely’s CEO confirmed this after building the full financial comparison himself.
- 🔑 Non-dilutive capital works best when the use of proceeds is specific and measurable: customer acquisition, a strategic hire, an acquisition bridge, or a product buildout with clear ROI.
- 🔑 A clean cap table is a strategic asset at exit. Vyopta’s acquisition by HP was materially aided by four years of zero dilution, producing a preference stack that didn’t complicate deal economics for the buyer.
- 🔑 The timing of equity matters as much as the amount. UnityLab used non-dilutive capital to prove its Hoffman acquisition thesis before raising a Series A, capturing a materially higher valuation at the moment evidence was strongest.
- 🔑 The VC “no” muscle is a legitimate founder skill. Jack Jia turned down equity investors consistently for over a decade. That discipline, not luck, created the conditions in which a $360M non-dilutive deal was available and appropriate.
